Targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2 crossover patient outcomes.
P. Shah (London, United Kingdom), A. Valipour (Vienna, Austria), C. Pison (Grenoble, France), C. Schumann (Kempten, Germany), P. Bonta (Amsterdam, Netherlands), R. Kessler (Strasborg, France), W. Gesierich (München, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), D. Skowasch (Bonn, Germany), D. Slebos (Groningen, Netherlands)
Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology
Session: The hot and cold of interventional pulmonology
Session type: Oral Presentation
Number: 3775
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Shah (London, United Kingdom), A. Valipour (Vienna, Austria), C. Pison (Grenoble, France), C. Schumann (Kempten, Germany), P. Bonta (Amsterdam, Netherlands), R. Kessler (Strasborg, France), W. Gesierich (München, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), D. Skowasch (Bonn, Germany), D. Slebos (Groningen, Netherlands). Targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2 crossover patient outcomes.. 3775
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Targeted lung denervation: interventions in moderate COPD patients Source: International Congress 2019 – Interventional pneumology: live out of the box round two Year: 2019
Two-year safety of targeted lung denervation in patients with moderate to severe COPD Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006
STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016
Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016
Maintenance of bronchodilation following tiotropium in patients with mild, moderate and severe COPD in one year clinical trials Source: Eur Respir J 2001; 18: Suppl. 33, 331s Year: 2001
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma Source: ERJ Open Res, 6 (1) 00204-2019; 10.1183/23120541.00204-2019 Year: 2020
Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013
The influence of lung volume reduction surgery on exercise in patients with COPD Source: Eur Respir J 2004; 23: 269-274 Year: 2004
Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial Source: Eur Respir J, 51 (1) 1701107; 10.1183/13993003.01107-2017 Year: 2018
Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Effects of inspiratory muscle training on dyspnea in severe COPD patients during pulmonary rehabilitation : controlled randomized trial Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease Year: 2017
Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006
Interval exercise for patients with severe COPD – randomised trial [SRCTN11611768] Source: Annual Congress 2006 - Organisation and programmes in pulmonary rehabilitation Year: 2006
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Neuromuscular electrical stimulation can improve whole-body exercise capacity and quality of life in patients with COPD: a randomized and controlled study Source: Annual Congress 2006 - Organisation and programmes in pulmonary rehabilitation Year: 2006
A randomised controlled trial of individualised, progressed early exercise in patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Source: Eur Respir J 2002; 20: 245 Year: 2002
Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013